INSTRUCTIONS FOR AUTHORS

Please read the abstract guidelines below carefully before submitting your abstract. You will receive an email upon submission, ensure to check your SPAM mail if you do not get it in your inbox. In case you do not receive the confirmation email in 30 mins, please do not resubmit the abstract, contact the Conference Secretariat at camhero2021@gmail.com for assistance.

SUBMISSION GUIDELINES

• The text should not exceed 300 words (excluding abstract title and authors);
• Add a maximum of 3 keywords.
• All abstract must be submitted via cam-hero.org. First register then submit your abstract. But if you already have an account, just login and update your profile.
• Abstracts sent by fax, post or email will not be accepted;
• A maximum of 2 graphics and 2 tables can be uploaded as an attachment upon submission. These will not add to the word count;

• Modifications can be made until the abstract submission deadline.
• A confirmation of receipt will be sent via email upon submission of an abstract.
• All abbreviations must be defined in brackets during the first utilisation, before being used in the text.
• Avoid formulas.
• For drugs, use only the scientific name.
• Do not include references, research grants or stock options.
• The title should be typed in capitals bold and should not exceed more than 100 characters; titles with more than 100 characters will be truncated.
• It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as submitted by the author.
• No endnotes or frames are acceptable.

ABSTRACT STRUCTURE

Option 1: Research Studies

This format is applicable to research across various disciplines. Abstracts following Option 1 should include brief statements on:

• Background: State the research’s purpose, objectives, hypothesis, or problem being analyzed or evaluated.
• Methods: Outline the study’s duration, setting, design, population, data collection methods, and analysis techniques.
• Results: Clearly and thoroughly present the study’s findings or outcomes. Summarize key results.
• Conclusions: Discuss the significance of the findings for HIV prevention, treatment, care, or support, and highlight the future implications.

Option 2: Program, Project, or Policy Lessons Learned

This format is suitable for abstracts derived from program, project, or policy implementation and management. Abstracts under Option 2 should include:

• Background: Provide an overview of the program, project, or policy’s purpose, scope, and objectives.
• Description: Detail the program, project, or policy’s duration, setting, location, structure, and the activities and interventions undertaken.
• Lessons Learned: Present detailed findings or outcomes, including an analysis of lessons learned and best practices. Summarize specific results that support these lessons and practices.
• Conclusions/Next Steps: Explain the significance of the findings for HIV prevention, treatment, care, or support, and discuss the future implications.

Basic Science:

This category involves original investigations that broaden our understanding of the biological and biochemical aspects of HIV/AIDS. This can include studies examining the virus’s structure, replication mechanisms, host-virus interactions, immunological responses, and genetic factors. It can also feature research into new potential therapeutic targets for antiretroviral therapies.

Clinical Science:

Abstracts under this category should focus on the clinical aspects of HIV/AIDS, such as case studies, clinical trials, drug efficacy and safety assessments, diagnostic tools, and management of patient health. This may also involve exploring co-infections, co-morbidities, long-term health implications of living with HIV/AIDS, and advancements in treatment modalities.

Prevention Science:

This category seeks to encompass research directed towards the prevention of HIV transmission and acquisition. Studies could address a range of interventions including, but not limited to, behavioural interventions, condom use, Pre-Exposure Prophylaxis (PrEP), post-exposure prophylaxis (PEP), microbicides, vaccines, and other biomedical interventions.

Implementation Science:

This category is aimed at studies investigating the process of implementing interventions in real-world settings. This could involve the evaluation of strategies for improving access to and uptake of HIV testing, treatment, and care services; assessment of policy impact; scale-up of effective interventions; health systems strengthening; and studies identifying and addressing barriers to and facilitators of service delivery.

For any additional information regarding the conference please contact:

Gabriel Mabou: +237 6 8163 1178, gabriel.mabou@crenc.org

Dr Peter Ebasone, ebasone.kewir@crenc.org